Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis
US5906820A · kind A · utility
14Cited by
2References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 5, 1997 |
| Grant date | May 25, 1999 |
| Priority date | — |
| Expiry date | May 5, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/75
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features a method for treating a patient having inflammatory arthritis, the method includes administering to the patient a molecule which is capable of specifically binding to an epidermal growth factor receptor expressed on a cell of the patient which contributes to the inflammatory arthritis of the patient, the molecule being capable of decreasing the viability of the cell.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.